Protein kinase A and its role in human neoplasia: The Carney complex paradigm

Endocrine-Related Cancer

Volumn 11, Issue 2, 2004, Pages 265-280

  Bossis, I ^a   Voutetakis, A ^a   Bei, T ^a   Sandrini, F ^a   Griffin, K J ^a   Stratakis, C A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ADRENAL HYPERPLASIA; ANIMAL MODEL; CARNEY COMPLEX; CELL CYCLE; CLINICAL FEATURE; CUSHING SYNDROME; GENE MUTATION; HUMAN; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; MYXOMA; NEOPLASM; NONHUMAN; PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE; REVIEW; SKIN PIGMENTATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; PROTEINS;

EID: 3042547294     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0110265     Document Type: Review

References (157)

1. Amieux PS & McKnight GS 2002 The essential role of RI alpha in the maintenance of regulated PKA activity. Annals of the New York Academy of Sciences 968 75-95.
2. Amieux PS, Howe DG, Knickerbocker H, Lee DC, Su T, Laszlo GS, Idzerda RL & McKnight GS 2002 Increased basal cAMP-dependent protein kinase activity inhibits the formation of mesoderm-derived structures in the developing mouse embryo. Journal of Biological Chemistry 277 27294-27304.
3. Andersen SS 1999 Balanced regulation of microtubule dynamics during the cell cycle: a contemporary view. Bioessays 21 53-60.
4. Angelo R & Rubin CS 1998 Molecular characterization of an anchor protein (AKAPCE) that binds the RI subunit (RCE) of type I protein kinase A from Caenorhabditis elegans. Journal of Biological Chemistry 273 14633-14643.
5. Atherton DJ, Pitcher DW, Wells RS & MacDonald DM 1980 A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. British Journal of Dermatology 103 421-429.
6. Balczon R 1996 The centrosome in animal cells and its functional homologs in plant and yeast cells. International Review of Cytology 169 25-82.
7. Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, Sharpless NE, Loda M, Carrasco DR & DePinho RA 2002 Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419 162-167.
8. Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X & Stratakis CA 2003 Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Research 63 5308-5319.
9. Bradbury AW, Carter DC, Miller WR, Cho-Chung YS & Clair T 1994 Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. British Journal of Cancer 69 738-742.
10. Carlson CC, Smithers SL, Yeh KA, Burnham LL & Dransfield DT 1999 Protein kinase A regulatory subunits in colon cancer. Neoplasia 1 373-378.
11. Carney JA 1990 Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. American Journal of Surgical Pathology 14 206-222.
12. Carney JA 1995 Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Seminars in Dermatology 14 90-98.
13. Carney JA & Stratakis CA 1996 Ductal adenoma of the breast and the Carney complex. American Journal of Surgical Pathology 20 1154-1155.
14. Carney JA & Stratakis CA 1998 Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex. Seminars in Diagnostic Pathology 15 216-224.
15. Carney JA & Toorkey BC 1991 Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. American Journal of Surgical Pathology 15 722-731.
16. Carney JA & Young WF 1992 Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 2 6-21.
17. Carney JA, Hruska LS, Beauchamp GD & Gordon H 1985a Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clinic Proceedings 61 165-172.
18. Carney JA, Gordon H, Carpenter PC, Shenoy BV & Go VL 1985b The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 64 270-283.
19. Carney JA, Boccon-Gibod L, Jarka DE, Tanaka Y, Swee RG, Unni KK & Stratakis CA 2001 Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. American Journal of Surgical Pathology 25 164-176.
20. Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, Korf B, Irvine AD, Hughes A, Carney JA, Stratakis CA & Basson CT 1998 Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 98 2560-2566.
21. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC & Basson CT 2000 Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. Journal of Clinical Investigation 106 R31-R38.
22. Cassimeris L 1999 Accessory protein regulation of microtubule dynamics throughout the cell cycle. Current Opinion in Cell Biology 11 134-141.
23. Chen X, Knauf JA, Gonsky R, Wang M, Lai EH, Chissoe S, Fagin JA & Korenberg JR 1998 From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. American Journal of Human Genetics 63 625-637.
24. Chin KV, Yang WL, Ravatn R, Kita T, Reitman E, Vettori D, Cvijic ME, Shin M & Iacono L 2002 Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling. Annals of the New York Academy of Sciences 968 49-64.
25. Cho-Chung YS, Pepe S, Clair T, Budillon A & Nesterova M 1995 cAMP-dependent protein kinase: role in normal and malignant growth. Critical Reviews in Oncology/Hematology 21 33-61.
26. Cho-Chung YS, Nesterova M, Pepe S, Lee GR, Noguchi K, Srivastava RK, Srivastava AR, Alper O, Park YG & Lee YN 1999 Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment. Frontiers in Bioscience 4 D898-D907.
27. Ciardiello F & Tortora G 1998 Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. Clinical Cancer Research 4 821-828.
28. Ciardiello F, Tortora G, Kim N, Clair T, Ally S, Salomon DS & Cho-Chung YS 1990 8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. Journal of Biological Chemistry 265 1016-1020.
29. Ciardiello F, Pepe S, Bianco C, Baldassarre G, Ruggiero A, Bianco C, Selvam MP, Bianco AR & Tortora G 1993 Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 protooncogenes. International Journal of Cancer 53 438-443.
30. Ciruna B & Rossant J 2001 FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Developmental Cell 1 37-49.
31. Ciruna BG, Schwartz L, Harpal K, Yamaguchi TP & Rossant J 1997 Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 124 2829-2841.
32. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A & Avvedimento EV 2001 cAMP signaling selectively influences Ras effectors pathways. Oncogene 20 1186-1192.
33. Clair T, Ally S, Tagliaferri P, Robins RK & Cho-Chung YS 1987 Site-selective cAMP analogs induce nuclear translocation of the RII cAMP receptor protein in Ha-MuSV-transformed NIH/3T3 cells. FEBS Letters 224 377-384.
34. Clegg CH, Cadd GG & GS McKnight GS 1988 Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. PNAS 85 3703-3707.
35. Colledge M & Scott JD 1999 AKAPs: from structure to function. Trends in Cell Biology 9 216-221.
36. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL & McKnight GS 1996 Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 382 622-626.
37. Cvijic ME & Chin KV 1997 Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants. Cell Growth and Differentiation 8 1243-1247.
38. Dell'Acqua ML & Scott JD 1997 Protein kinase A anchoring. Journal of Biological Chemistry 272 12881-12884.
39. De Marco L, Stratakis CA, Boson WL, Jakbovitz O, Carson E, Andrade LM, Amaral VF, Rocha JL, Choursos GP, Nordenskjold M & Friedman E 1996 Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gs alpha gene. Human Genetics 98 185-188.
40. De Moor P, Roels H, Delaere K & Crabbé J 1965 Unusual case of adrenocortical hyperfunction. Journal of Clinical Endocrinology and Metabolism 25 612-620.
41. Desai A & Mitchison TJ 1997 Microtubule polymerization dynamics. Annual Review of Cell and Developmental Biology 13 83-117.
42. Dictenberg JB, Zimmerman W, Sparks CA, Young A, Vidair C, Zheng Y, Carrington W, Fay FS & Doxsey SJ 1998 Pericentrin and gamma-tubulin form a protein complex and are organized into a novel lattice at the centrosome. Journal of Cell Biology 141 163-174.
43. Diviani D & Scott JD 2001 AKAP signaling complexes at the cytoskeleton. Journal of Cell Science 14 1431-1437.
44. Diviani D, Langeberg LK, Doxsey SJ & Scott JD 2000 Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain. Current Biology: CB 10 417-420.
45. Doxsey S 2001 Re-evaluating centrosome function. Nature Reviews. Molecular Cell Biology 2 688-698.
46. Doxsey SJ, Stein P, Evans L, Calarco PD & Kirschner M 1994 Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell 76 639-650.
47. Dremier S, Coulonval K, Perpete S, Vandeput F, Fortemaison N, Van Keymeulen A, Deleu S, Ledent C, Clement S, Schurmans S, Dumont JE, Lamy F, Roger PP & Maenhaut C 2002 The role of cyclic AMP and its effect on protein kinase A in the mitogenic action of thyrotropin on the thyroid cell. Annals of the New York Academy of Sciences 968 106-121.
48. Emanuel RL, Iwasaki Y, Arbiser ZK, Velez EM, Emerson CH & Majzoub JA 1998 Vasopressin messenger ribonucleic acid regulation via the protein kinase A pathway. Endocrinology 139 2831-2837.
49. Faux MC & Scott JD 1996 More on target with protein phosphorylation: conferring specificity by location. Trends in Biochemical Sciences 21 312-315.
50. Fogt F, Zimmerman RL, Hartmann CJ, Brown CA & Narula N 2002 Genetic alterations of Carney complex are not present in sporadic cardiac myxomas. International Journal of Molecular Medicine 9 59-60.
51. Foss KB, Landmark B, Skalhegg BS, Tasken K, Jellum E, Hansson V & Jahnsen T 1994 Characterization of in-vitro-translated human regulatory and catalytic subunits of cAMP-dependent protein kinases. European Journal of Biochemistry 220 217-223.
52. Fossberg TM, Doskeland SO & Ueland PM 1978 Protein kinases in human renal cell carcinoma and renal cortex. A comparison of isozyme distribution and of responsiveness to adenosine 3′:5′-cyclic monophosphate. Archives of Biochemistry and Biophysics 189 272-281.
53. Furuta Y, Ilic D, Kanazawa S, Takeda N, Yamamoto T & Aizawa S 1995 Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. Oncogene 11 1989-1995.
54. Gamm DM, Baude EJ & Uhler MD 1996 The major catalytic subunit isoforms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo. Journal of Biological Chemistry 271 15736-15742.
55. Georges-Labouesse EN, George EL, Rayburn H & Hynes RO 1996 Mesodermal development in mouse embryos mutant for fibronectin. Developmental Dynamics 207 145-156.
56. Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G & Ried T 2000 Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes, Chromosomes and Cancer 27 183-190.
57. Glover DM, Hagan IM & Tavares AA 1998 Polo-like kinases: a team that plays throughout mitosis. Genes and Development 12 3777-3787.
58. Gomez-Muguruza MT & Chrousos GP 1989 Periodic Cushing syndrome in a short boy: usefulness of the ovine corticotrophin releasing hormone test. Journal of Pediatrics 115 270-273.
59. Gradin HM, Larsson N, Marklund U & Gullberg M 1998 Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells. Journal of Cell Biology 140 131-141.
60. Griffioen G & Thevelein JM 2002 Molecular mechanisms controlling the localisation of protein kinase A. Current Genetics 41 199-207.
61. Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA & Bertherat J 2002a Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. American Journal of Human Genetics 71 1433-1442.
62. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, Bertagna X & Bertherat J 2002b Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. Journal of Clinical Endocrinology and Metabolism 87 4324-4329.
63. Gustafson LM, Gleich LL, Fukasawa K, Chadwell J, Miller MA, Stambrook PJ & Gluckman JL 2000 Centrosome hyperamplification in head and neck squamous cell carcinoma: a potential phenotypic marker of tumor aggressiveness. Laryngoscope 110 1798-1801.
64. Han JD & Rubin CS 1996 Regulation of cytoskeleton organization and paxillin dephosphorylation by cAMP. Studies on murine Y1 adrenal cells. Journal of Biological Chemistry 271 29211-29215.
65. Handschin JC & Eppenberger U 1979 Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors. FEBS Letters 106 301-304.
66. Howell B, Larsson N, Gullberg M & Cassimeris L 1999 Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin. Molecular Biology of the Cell 10 105-118.
67. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M & Yamamoto T 1995 Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377 539-544.
68. Imaizumi-Scherrer T, Faust DM, Barradeau S, Hellio R & Weiss MC 2001 Type I protein kinase A is localized to interphase microtubules and strongly associated with the mitotic spindle. Experimental Cell Research 264 250-265.
69. Jiang J & Struhl G 1995 Protein kinase A and hedgehog signaling in Drosophila limb development. Cell 80 563-572.
70. Jones KW, Shapero MH, Chevrette M & Fournier RE 1991 Subtractive hybridization cloning of a tissue-specific extinguisher: TSE1 encodes a regulatory subunit of protein kinase A. Cell 66 861-872.
71. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M & Grossman AB 2002 Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clinical Endocrinology 57 443-448.
72. Keryer G, Skalhegg BS, Landmark BF, Hansson V, Jahnsen T & Tasken K 1999 Differential localization of protein kinase A type II isozymes in the Golgi-centrosomal area. Experimental Cell Research 249 131-146.
73. Kirschner LS, Taymans SE, Pack S, Pak E, Pike BL, Chandrasekharappa SC, Zhuang Z & Stratakis CA 1999 Genomic mapping of chromosomal region 2p 15-p21 (D2S378-D2S391): integration of Genemap'98 within a framework of yeast and bacterial artificial chromosomes. Genomics 62 21-33.
74. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS & Stratakis CA 2000a Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genetics 26 89-92.
75. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA & Stratakis CA 2000b Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Human Molecular Genetics 9 3037-3046.
76. Kjellman M, Roshani L, Teh BT, Kallioniemi OP, Hoog A, Gray S, Farnebo LO, Holst M, Backdahl M & Larsson C 1999 Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. Journal of Clinical Endocrinology and Metabolism 84 730-735.
77. Klinghoffer RA, Sachsenmaier C, Cooper JA & Soriano P 1999 Src family kinases are required for integrin but not PDGFR signal transduction. EMBO Journal 18 2459-2471.
78. Knauf JA, Elisei R, Mochly-Rosen D, Liron T, Chen XN, Gonsky R, Korenberg JR & Fagin JA 1999 Involvement of protein kinase C epsilon (PKC epsilon) in thyroid cell death. A truncated chimeric PKC epsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. Journal of Biological Chemistry 274 23414-23425.
79. Kotani S, Tugendreich S, Fujii M, Jorgensen PM, Watanabe N, Hoog C, Hieter P & Todokoro K 1998 PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Molecular Cell 1 371-380.
80. Kotani S, Tanaka H, Yasuda H & Todokoro K 1999 Regulation of APC activity by phosphorylation and regulatory factors. Journal of Cell Biology 146 791-800.
81. Kussel-Andermann P, El-Amraoui A, Safieddine S, Hardelin JP, Nouaille S, Camonis J & Petit C 2000 Unconventional myosin VIIA is a novel A-kinase-anchoring protein. Journal of Biological Chemistry 275 29654-29659.
82. Larsson N, Marklund U, Gradin HM, Brattsand G & Gullberg M 1997 Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Molecular and Cellular Biology 17 5530-5539.
83. Le T & Schimmer BP 2001 The regulation of MAPKs in Y1 mouse adrenocortical tumor cells. Endocrinology 142 4282-4287.
84. Ledinko N & Chan IJ 1984 Increase in type I cyclic adenosine 3′:5′-monophosphate-dependent protein kinase activity and specific accumulation of type I regulatory subunits in adenovirus type 12-transformed cells. Cancer Research 44 2622-2627.
85. Lengauer C, Kinzler KW & Vogelstein B 1998 Genetic instabilities in human cancers. Nature 396 643-649.
86. Lepage T, Cohen SM, Diaz-Benjumea FJ & Parkhurst SM 1995 Signal transduction by cAMP-dependent protein kinase A in Drosophila limb patterning. Nature 373 711-715.
87. Li W, Ohlmeyer JT, Lane ME & Kalderon D 1995 Function of protein kinase A in hedgehog signal transduction and Drosophila imaginal disc development. Cell 80 553-562.
88. Liebmann C 2001 Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cellular Signalling 13 777-785.
89. Liu B, Cvijic ME, Jetzt A & Chin KV 1996 Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants. Cell Growth and Differentiation 7 1105-1112.
90. Liu J, Huang C & Zhan X 1999 Src is required for cell migration and shape changes induced by fibroblast growth factor 1. Oncogene 18 6700-6706.
91. Livesey SA, Kemp BE, Re CA, Partridge NC & Martin TJ 1982 Selective hormonal activation of cyclic AMP-dependent protein kinase isoenzymes in normal and malignant osteoblasts. Journal of Biological Chemistry 257 14983-14987.
92. Lotfi CF, Todorovic Z, Armelin HA & Schimmer BP 1997 Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells. Journal of Biological Chemistry 272 29886-29891.
93. Lutz W, Lingle WL, McCormick D, Greenwood TM & Salisbury JL 2001 Phosphorylation of centrin during the cell cycle and its role in centriole separation preceding centrosome duplication. Journal of Biological Chemistry 276 20774-20780.
94. Matyakhina L, Pack S, Kirschner LS, Pak E, Mannan P, Jaikumar J, Taymans SE, Sandrini F, Carney JA & Stratakis CA 2003 Chromosome 2 (2p16) abnormalities in Carney complex tumours. Journal of Medical Genetics 40 268-277.
95. McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, Gilmore P & Johnston PG 1999 Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. British Journal of Cancer 79 933-939.
96. McKnight GS, Clegg CH, Uhler MD, Chrivia JC, Cadd GG, Correll LA & Otten AD 1988 Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches. Recent Progress in Hormone Research 44 307-335.
97. McKnight GS, Cummings DE, Amieux PS, Sikorski MA, Brandon EP, Planas JV, Motamed K & Idzerda RL 1998 Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Progress in Hormone Research 53 139-159.
98. Mendelsohn J & Liotta L (eds) 1995 The Molecular Basis of Cancer. Philadelphia, PA: Saunders.
99. Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC & Smeland EB 1999 Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. Journal of Cellular Physiology 180 71-80.
100. Nakajima F, Imashuku S, Wilimas J, Champion JE & Green AA 1984 Distribution and properties of type I and type II binding proteins in the cyclic adenosine 3′:5′-monophosphate-dependent protein kinase system in Wilms' tumor. Cancer Research 44 5182-5187.
101. Nigg EA 2001 Mitotic kinases as regulators of cell division and its checkpoints. Nature Reviews. Molecular Cell Biology 2 21-32.
102. Ou Y & Rattner JB 2000 A subset of centrosomal proteins are arranged in a tubular conformation that is reproduced during centrosome duplication. Cell Motility and the Cytoskeleton 47 13-24.
103. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA & Stratakis CA 2000 Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). Journal of Clinical Endocrinology and Metabolism 85 3860-3865.
104. Pan D & Rubin GM 1995 cAMP-dependent protein kinase and hedgehog act antagonistically in regulating decapentaplegic transcription in Drosophila imaginal discs. Cell 80 543-552.
105. Pihan GA & Doxsey SJ 1999 The mitotic machinery as a source of genetic instability in cancer. Seminars in Cancer Biology 9 289-302.
106. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P & Doxsey SJ 1998 Centrosome defects and genetic instability in malignant tumors. Cancer Research 58 3974-3985.
107. Piroli G, Weisenberg LS, Grillo C & De Nicola AF 1990 Subcellular distribution of cyclic adenosine 3′,5′-monophosphate-binding protein and estrogen receptors in control pituitaries and estrogen-induced pituitary tumors. Journal of the National Cancer Institute 82 596-601.
108. Premkumar A, Stratakis CA, Shawker TH, Papanicolaou DA & Chrousos GP 1997 Testicular ultrasound in Carney complex: report of three cases. Journal of Clinical Ultrasound 25 211-214.
109. Purohit A, Tynan SH, Vallee R & Doxsey SJ 1999 Direct interaction of pericentrin with cytoplasmic dynein light intermediate chain contributes to mitotic spindle organization. Journal of Cell Biology 147 481-492.
110. Pursiheimo JP, Jalkanen M, Tasken K & Jaakkola P 2000 Involvement of protein kinase A in fibroblast growth factor-2-activated transcription. PNAS 97 168-173.
111. Pursiheimo JP, Kieksi A, Jalkanen M & Salmivirta M 2002 Protein kinase A balances the growth factor-induced Ras/ ERK signaling. FEBS Letters 521 157-164.
112. Raff SB, Carney JA, Krugman D, Doppman JL & Stratakis CA 2000 Prolactin secretion abnormalities in patients with the 'syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). Journal of Pediatric Endocrinology and Metabolism 13 373-379.
113. Rhodes AR, Silverman RA, Harrist TJ & Perez-Atayde AR 1984 Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the 'LAMB' syndrome. Journal of the American Academy of Dermatology 10 72-82.
114. Robinson-White A, Hundley TR, Shiferaw M, Bertherat J, Sandrini F & Stratakis CA 2003 Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2. Human Molecular Genetics 12 1475-1484.
115. Sandrini F & Stratakis C 2003 Clinical and molecular genetics of Carney complex. Molecular Genetics and Metabolism 78 83-92.
116. Sandrini F, Kirschner LS, Carney AJ & Stratakis CA 2001 Assessment of protein kinase A subunit expression in normal adrenal cortex and primary pigmented adrenocortical disease (PPNAD) and cell lines from patients with and without CNC and PRKAR1A mutations. 83rd Annual Meeting of the Endocrine Society, Denver, CO, USA.
117. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrell WE, Clayton RN, Groussin L, Bertherat J & Stratakis CA 2002a PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. Journal of Medical Genetics 39 78.
118. Sandrini F, Matyakhina L, Sarlis NJ, Kirschner LS, Farmakidis C, Gimm O & Stratakis CA 2002b Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. Genes, Chromosomes and Cancer 35 182-192.
119. Sandrini F, Bertherat J, Rosenberg D, Groussin L, Bei T, Lorang D, Libutti SK, Kirschner LS, Carney JA, Bertagna X & Stratakis CA 2002c Effectors of tumorigenicity in primary pigmented nodular adrenortical disease (PPNAD): protein kinase-A (PKA) subunit expression and activity, laser-capture microdissection (LCM) for LOH and CREB phosphorylation. (OR36-2). 84th Annual Meeting of the Endocrine Society, San Francisco, CA, USA.
120. Sato N, Mizumoto K, Nakamura M, Maehara N, Minamishima YA, Nishio S, Nagai E & Tanaka M 2001 Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genetics and Cytogenetics 126 13-19.
121. Schimmer BP 1995 The 1994 Upjohn Award Lecture. Molecular and genetic approaches to the study of signal transduction in the adrenal cortex. Canadian Journal of Physiology and Pharmacology 73 1097-1107.
122. Schmidt PH, Dransfield DT, Claudio JO, Hawley RG, Trotter KW, Milgram SL & Goldenring JR 1999 AKAP350, a multiply spliced protein kinase A-anchoring protein associated with centrosomes. Journal of Biological Chemistry 274 3055-3066.
123. Scott JD 1991 Cyclic nucleotide-dependent protein kinases. Pharmacology and Therapeutics 50 123-145.
124. Sewing A & Muller R 1994 Protein kinase A phosphorylates cyclin D1 at three distinct sites within the cyclin box and at the C-terminus. Oncogene 9 2733-2736.
125. Shenoy BV, Carpenter PC & Carney JA 1984 Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. American Journal of Surgical Pathology 8 335-344.
126. Skalhegg BS & Tasken K 1997 Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Frontiers in Bioscience 2 D331-D342.
127. Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL & Ferris DK 1997 Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochemical and Biophysical Research Communications 234 397-405.
128. Steinbeck RG 1998 Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. British Journal of Cancer 77 1027-1033.
129. Stratakis CA 2000 Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. Frontiers in Bioscience 5 D353-D366.
130. Stratakis CA 2001 Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. Journal of Endocrinological Investigation 24 370-383.
131. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E & Chrousos GP 1996 Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of II kindreds and linkage to the short arm of chromosome 2. Journal of Clinical Investigation 97 699-705.
132. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA & Shawker T 1997 Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). Journal of Clinical Endocrinology and Metabolism 82 2037-2043.
133. Stratakis CA, Kirschner LS & Carney JA 1998 Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas. American Journal of Medical Genetics 80 183-185.
134. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP & Papanicolaou DA 1999 Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Annals of Internal Medicine 131 585-591.
135. Stratakis CA, Papageorgiou T, Premkumar A, Pack S, Kirschner LS, Taymans SE, Zhuang Z, Oelkers WH & Carney JA 2000 Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. Journal of Clinical Endocrinology and Metabolism 85 4359-4366.
136. Stratakis CA, Kirschner LS & Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism 86 4041-4046.
137. Strutt DI, Wiersdorff V & Mlodzik M 1995 Regulation of furrow progression in the Drosophila eye by cAMP-dependent protein kinase A. Nature 373 705-709.
138. Sun X, Meyers EN, Lewandoski M & Martin GR 1999 Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes and Development 13 1834-1846.
139. Tagliaferri P, Clair T, DeBortoli ME & Cho-Chung YS 1985 Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH/3T3 cells transfected with Ha-MuSV DNA. Biochemical and Biophysical Research Communications 130 1193-1200.
140. Takahashi M, Shibata H, Shimakawa M, Miyamoto M, Mukai H & Ono Y 1999 Characterization of a novel giant scaffolding protein, CG-NAP, that anchors multiple signaling enzymes to centrosome and the Golgi apparatus. Journal of Biological Chemistry 274 17267-17274.
141. Tasken K, Skalhegg BS, Solberg R, Andersson KB, Taylor SS, Lea T, Blomhoff HK, Jahnsen T & Hansson V 1993 Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RI alpha-RI beta heterodimeric complexes. Journal of Biological Chemistry 268 21276-21283.
142. Tasken K, Skalhegg BS, Tasken KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V & Jahnsen T 1997 Structure, function, and regulation of human cAMP-dependent protein kinases. Advances in Second Messenger and Phosphoprotein Research 31 191-204.
143. Tortora G, Ciardiello F, Ally S, Clair T, Salomon DS & Cho-Chung YS 1989 Site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate inhibits transformation and transforming growth factor alpha production in Ki-ras-transformed rat fibroblasts. FEBS Letters 242 363-367.
144. Tortora G, Yokozaki H, Pepe S, Clair T & Cho-Chung YS 1991 Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. PNAS 88 2011-2015.
145. Tortora G, Damiano V, Bianco C, Baldassarre G, Bianco AR, Lanfrancone L, Pelicci PG & Ciardiello F 1997 The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene 14 923-928.
146. Vallee RB, DiBartolomeis MJ & Theurkauf WE 1981 A protein kinase bound to the projection portion of MAP 2 (microtubule-associated protein 2). Journal of Cell Biology 90 568-576.
147. Van Oirschot BA, Stahl M, Lens SM & Medema RH 2001 Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. Journal of Biological Chemistry 76 33854-33860.
148. Wang L, Sunahara RK, Krumins A, Perkins G, Crochiere ML, Mackey M, Bell S, Ellisman MH & Taylor SS 2001 Cloning and mitochondrial localization of full-length D-AKAP2, a 'protein kinase A anchoring protein. PNAS 98 3220-3225.
149. Watson DM, Hawkins RA, Bundred NJ, Stewart HJ & Miller WR 1987 Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer. British Journal of Cancer 56 141-142.
150. Whitehead CM & Salisbury JL 1999 Regulation and regulatory activities of centrosomes. Journal of Cellular Biochemistry 32-33 (Suppl) 192-199.
151. Witczak O, Skalhegg BS, Keryer G, Bornens M, Tasken K, Jahnsen T & Orstavik S 1999 Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450. EMBO Journal 18 1858-1868.
152. Yamaguchi TP, Harpal K, Henkemeyer M & Rossant J 1994 Fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes and Development 8 3032-3044.
153. Yamasaki H, Mizusawa N, Nagahiro S, Yamada S, Sano T, Itakura M & Yoshimoto K 2003 GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clinical Endocrinology 58 464-470.
154. Yanagida M, Yamashita YM, Tatebe H, Ishii K, Kumada K & Nakaseko Y 1999 Control of metaphase-anaphase progression by proteolysis: cyclosome function regulated by the protein kinase A pathway, ubiquitination and localization. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 354 1559-1569.
155. Yasui W & Tahara E 1985 Effect of gastrin on gastric mucosal cyclic adenosine 3′:5′-monophosphate-dependent protein kinase activity in rat stomach carcinogenesis induced by N-methyl-N′-nitro-N- nitrosoguanidine. Cancer Research 45 4763-4767.
156. Zachariae W 1999 Progression into and out of mitosis. Current Opinion in Cell Biology 11 708-716.
157. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR & Sen S 1998 Tumour amplified kinase STK15/ BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genetics 20 189-193.